Show your heart a little love this Valentine’s Day.
Take the Listen To Your Heart Challenge!
Everyone who completes the challenge by Heart Valve Disease Awareness Day
(February 22) will be entered to win a $50 Amazon gift card.
The Alliance is proud to share that Cynthia Bens, our Vice President of Public Policy, will present on a panel at the DIA 28th Annual EuroMeeting in Hamburg, Germany:
Frailty as a Baseline Stratification Parameter and Potential Therapeutic Target
April 7, 2016
11:00 AM – 12:30 PM (Central European Standard Time)
Track: Special Populations
Session Number: S1102
Progress made in drug development for and with older people? This session will announce and discuss the brand new EMA Geriatric Working Party frailty definition selected for study baseline characteristics for clinical studies and propose how this will change the research landscape in geriatric studies in Europe and beyond.
Chair: Florian von Raison, Dr Med
Senior Global Program Head and Chairman
Geriatric Medicine Working Party/ EFGCP
Novartis Pharma AG, Switzerland
Presentation(s) & Speaker(s):
The EMA Geriatric Medicines Strategy, Good Pharmacovigilance Practice (GVP) and What Leads Us to Single out Frailty
Medicines & Healthcare Products Regulatory Agency (MHRA)
Susanna Del Signore, MD
Director and Founder
The Frailty Guideline under Consultation: What Does It Mean in Terms of CT Population and Registries
Head of Geriatrics
Addressing Areas of Need / Insufficient Research
VP, Public Policy
Alliance for Aging Research
Francesca Cerreta, PharmD, MPharm, MS
Senior Scientific Officer
European Medicines Agency
European Union, United Kingdom
The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.
The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.